Detalhe da pesquisa
1.
Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations.
Ann Oncol
; 31(2): 289-294, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959346
2.
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial.
Ann Oncol
; 30(12): 1985-1991, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31584608
3.
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Ann Oncol
; 28(5): 1078-1083, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327934
4.
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial.
Ann Oncol
; 26(5): 908-914, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25688059
5.
EPICC study: evaluation of pharmaceutical intervention in cancer care.
J Clin Pharm Ther
; 40(2): 196-203, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25594148
6.
Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.
Ann Oncol
; 24(6): 1548-52, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23406729
7.
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).
Ann Oncol
; 24(3): 586-97, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136229
8.
Earlier onset and poor prognosis of lung cancer in imprisoned patients.
Oncology
; 85(6): 370-7, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335502
9.
[Oral and mucosal lichenoid drug eruption under anti-PD-1]. / Éruption lichénoïde cutanéo-muqueuse sous anti-PD-1.
Ann Dermatol Venereol
; 145(11): 725-727, 2018 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-30126642
10.
Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changes.
Lung Cancer
; 177: 29-36, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701841
11.
[Management of immunotherapy in patients with non-small cell lung cancer presenting durable oncological response]. / Prescription de l'immunothérapie chez les patients « long-répondeurs ¼.
Rev Mal Respir
; 39(7): 578-586, 2022 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-35909007
12.
IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
ESMO Open
; 7(1): 100353, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953398
13.
Renal adverse effects of immune checkpoints inhibitors in clinical practice: ImmuNoTox study.
Eur J Cancer
; 147: 29-39, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607383
14.
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
ESMO Open
; 6(5): 100273, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607285
15.
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Lung Cancer
; 151: 69-75, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248711
16.
[Best practice agreement: implementation of best practice guidelines in HCL hospitals in Lyon, France]. / Contrat de bon usage : mise en oeuvre opérationnelle des référentiels de bon usage aux hospices civils de Lyon.
Ann Pharm Fr
; 68(3): 148-56, 2010 May.
Artigo
em Francês
| MEDLINE | ID: mdl-20569771
17.
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]. / Prise en charge des effets dermatologiques sous erlotinib. Résultats de l'étude PRECEDE.
Cancer Radiother
; 13(2): 97-102, 2009 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-19246229
18.
[FDG-PET-CT and the diagnosis of malignancy of pulmonary nodules and mass lesions]. / TEP-TDM-FDG et diagnostic de malignité des nodules et masses pulmonaires.
Rev Mal Respir
; 25(1): 33-41, 2008 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-18288049
19.
[Thymic tumours, autoimmune neutropaenia and autoimmune haemolytic anaemia]. / Tumeurs épithéliales thymiques, neutropénie et anémie hémolytique auto-immunes.
Rev Mal Respir
; 25(5): 605-9, 2008 May.
Artigo
em Francês
| MEDLINE | ID: mdl-18535529
20.
[How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]. / Comment traiter la rechute du CBNPC après une chirurgie et chimiothérapie?
Rev Mal Respir
; 25(1): 91-6, 2008 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-18288059